NNC-0156-0000-0009

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NNC-0156-0000-0009, covering 2017-07-24 to 2018-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 [Phase 3]

See pricing